The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer. More than one in three people will develop cancer in their lifetime2 ...

from Hims & Hers is giving some medical experts pause. In addition to touting the company’s weight loss drugs and testosterone treatments, it promotes a controversial early cancer detection test.

Hims & Hers Health, Inc. HIMS shares are trading higher during Thursday's premarket session after the company backed the ...

HIMS is broadening its digital-first platform with Labs, hormone therapy and weight-loss programs as it scales personalized ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...